This may indicate an underlying issue that requires investigation, such as anemia, electrolyte disturbances, or thyroid dysfunction
Risk factors that might warrant consideration of medication adjustment include: Recent initiation or dose escalation of GLP-1 therapy Significant gastrointestinal symptoms (nausea, vomiting, early satiety) Maximum medication doses Known gastroparesis or other conditions affecting gastric emptying For patients where holding the medication is deemed appropriate, the duration should be individualized based on the specific medication, patient factors, and clinical judgment
Our members also get a discount of up to 30% off these IV services
For those who benefit from genetic testing, the Precision Peptide Genetic Testa 14-pathway, 49-peptide analysisis $298 and can be added after the first month of treatment
The prescription medication is geared toward individuals with obesity who have a BMI higher than 30 or who are overweight with a BMI of 27 or higher
How Shapely works 1 Check your coverage (2 min) Tell us about your insurance and health goals